Oakwood Labs is happy to announce that we will be exhibiting and speaking at the upcoming Partnership Opportunities in Drug Delivery (PODD). The event is from October 27-28 at the Westin Copley Place Hotel in Boston, MA. Oakwood will have be exhibiting at booth #317. Also, Colin Spencer from our technology transfer team will be presenting on “Chroniject Technology: A Solution to Long Acting Injectable Formulation and Scale-Up Challenges” during Track 1A Injectable Formulations and Technologies on Monday, October 27^th at 2:15pm  If you would like to learn more about the event, please visit the following link: https://poddconference.com/

Company Overview

Oakwood Labs is a global leading CDMO in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 28 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.

The two main offerings we are showcasing for the event are:

• CDMO services for long acting injectables
• CMO services for sterile injectable manufacturing

Contact Us for More Information

The PODD conference covers a broad range of industry updates and innovation within the drug delivery field, and we are happy to contribute to the 15^th event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!

We look forward to discussing our technology and CDMO/CMO capabilities.